HONG KONG: US pharmaceutical giant Eli Lilly has moved its Asia
Pacific corporate HQ from Singapore to Hong Kong in a bid to extend its
reach into Greater China. Product PR for the drug manufacturers' range
of OTC drugs is being stepped-up in China where Eli Lilly is looking to
launch new drugs this year.